Christopher Bunker BSc, PhD, MBA

Bunker is driven by his desire to have the greatest impact possible on the treatment of human disease. His scientific training is in cancer molecular biology and he have built on this with education and experience in business and commercial strategy. His success in driving adoption of technologies that will transform oncology therapeutic and diagnostic development has been achieved through the combined use of his scientific expertise and business acumen.